Clinical Trial Update: A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial (TH3RESA) comparing trastuzumab emtansine with physician's choice in HER2-positive breast cancer patients who had at least two prior HER2-direct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Kadcyla (ado-trastuzumab emtansine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-05-05